SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-24-025850
Filing Date
2024-08-09
Accepted
2024-08-09 16:01:37
Documents
19
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A tgtx20231231_10ka.htm   iXBRL 10-K/A 73903
2 EXHIBIT 23.1 ex_711435.htm EX-23.1 2410
3 EXHIBIT 31.1 ex_711518.htm EX-31.1 12179
4 EXHIBIT 31.2 ex_711519.htm EX-31.2 12519
5 EXHIBIT 32.1 ex_711520.htm EX-32.1 5432
6 EXHIBIT 32.2 ex_711521.htm EX-32.2 5717
  Complete submission text file 0001437749-24-025850.txt   341893

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20231231.xsd EX-101.SCH 3408
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20231231_def.xml EX-101.DEF 17404
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20231231_lab.xml EX-101.LAB 23724
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20231231_pre.xml EX-101.PRE 18444
21 EXTRACTED XBRL INSTANCE DOCUMENT tgtx20231231_10ka_htm.xml XML 8708
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-32639 | Film No.: 241192457
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)